A Binding Potency Assay for Pritumumab and Ecto-Domain Vimentin.
Sign Up to like & getrecommendations! Published in 2019 at "Methods in molecular biology"
DOI: 10.1007/978-1-4939-8958-4_19
Abstract: Pritumumab, a natural human IgG1kappa mAb, was isolated from the regional lymph node of a patient with cervical cancer. This antibody has been reported to bind the cytoskeletal protein vimentin, and to cell surface expressed… read more here.
Keywords: domain vimentin; assay pritumumab; potency; ecto domain ... See more keywords